Oral antibiotic treatment of staphylococcal bone and joint infections in adults.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Antimicrobial Chemotherapy

• Publication date

  2014-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/jac/dkt374PMID 24072167
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A large multicenter study of methicillin-susceptible and methicillin-resistant Staphylococcus aureus prosthetic joint infections managed with implant retention.

  2013cited by this paper
• Antibiotics for treating chronic osteomyelitis in adults.

  2013cited by this paper
• Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America.

  2013cited by this paper
• Factors associated with rifampin resistance in staphylococcal periprosthetic joint infections (PJI): a matched case–control study

  2013cited by this paper
• Clindamycin vs. first-generation cephalosporins for acute osteoarticular infections of childhood--a prospective quasi-randomized controlled trial.

  2012cited by this paper
• Fusidic acid for the treatment of bone and joint infections caused by meticillin-resistant Staphylococcus aureus.

  2012cited by this paper
• Antimicrobial Agents in Orthopaedic Surgery

  2012cited by this paper
• Outcome of Debridement and Retention in Prosthetic Joint Infections by Methicillin-Resistant Staphylococci, with Special Reference to Rifampin and Fusidic Acid Combination Therapy

  2012cited by this paper
• Antimicrobial treatment concepts for orthopaedic device-related infection.

  2012cited by this paper
• Linezolid plus Rifampin as a Salvage Therapy in Prosthetic Joint Infections Treated without Removing the Implant

  2011cited by this paper
• Trimethoprim-sulfamethoxazole Therapy for Children With Acute Osteomyelitis

  2011cited by this paper
• Treating Osteomyelitis: Antibiotics and Surgery

  2011cited by this paper
• Antibiotic treatment for acute haematogenous osteomyelitis of childhood: moving towards shorter courses and oral administration.

  2011cited by this paper
• Role of early intravenous to oral antibiotic switch therapy in the management of prosthetic hip infection treated with one- or two-stage replacement.

  2011cited by this paper
• Outcome and Predictors of Treatment Failure in Total Hip/Knee Prosthetic Joint Infections Due to Staphylococcus aureus

  2011cited by this paper
• Efficacy of a combined oral clindamycin–rifampicin regimen for therapy of staphylococcal osteoarticular infections

  2011cited by this paper
• Systemic antibiotic therapy for chronic osteomyelitis in adults.

  2011cited by this paper
• Bacterial septic arthritis in adults.

  2010cited by this paper
• Use of Pristinamycin for Infections by Gram-Positive Bacteria: Clinical Experience at an Australian Hospital

  2010cited by this paper
• Vertebral Osteomyelitis

  2010cited by this paper
• Treatment with Linezolid or Vancomycin in Combination with Rifampin Is Effective in an Animal Model of Methicillin-Resistant Staphylococcus aureus Foreign Body Osteomyelitis

  2010cited by this paper
• Tolerability of prolonged linezolid therapy in bone and joint infection: protective effect of rifampicin on the occurrence of anaemia?

  2010cited by this paper
• Efficacy of moxifloxacin compared to teicoplanin in the treatment of implant‐related chronic osteomyelitis in rats

  2010cited by this paper
• Efficacy of Fosfomycin in Experimental Osteomyelitis Due to Methicillin-Resistant Staphylococcus aureus

  2010cited by this paper
• Safety and Efficacy of Moxifloxacin Monotherapy for Treatment of Orthopedic Implant-Related Staphylococcal Infections

  2010cited by this paper
• Rifampin Combination Therapy for Nonmycobacterial Infections

  2010cited by this paper
• Spondylodiscitis: update on diagnosis and management.

  2010cited by this paper
• Risk factors for treatment failure in orthopedic device-related methicillin-resistant Staphylococcus aureus infection

  2010cited by this paper
• Antimicrobial activities of trimethoprim/sulfamethoxazole, 5-iodo-2'-deoxyuridine and rifampicin against Staphylococcus aureus.

  2010cited by this paper
• Prosthetic joint infections: single versus combination therapy.

  2010cited by this paper
• Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections.

  2009cited by this paper
• Bactericidal Activity of the Combination of Levofloxacin with Rifampin in Experimental Prosthetic Knee Infection in Rabbits Due to Methicillin-Susceptible Staphylococcus aureus

  2009cited by this paper
• Management of methicillin-resistant Staphylococcus aureus infections.

  2009cited by this paper
• Antibiotics for treating chronic osteomyelitis in adults.

  2009cited by this paper
• Antibiotics for treating chronic osteomyelitis in adults (Review)

  2009cited by this paper
• High doses of levofloxacin vs moxifloxacin against staphylococcal experimental foreign-body infection: the effect of higher MIC-related pharmacokinetic parameters on efficacy.

  2009cited by this paper
• Penetration of Antibacterials into Bone

  2009cited by this paper
• High fosfomycin concentrations in bone and peripheral soft tissue in diabetic patients presenting with bacterial foot infection.

  2009cited by this paper
• Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations.

  2009cited by this paper
• Efficacy and tolerance of rifampicin-linezolid compared with rifampicin-cotrimoxazole combinations in prolonged oral therapy for bone and joint infections.

  2009cited by this paper
• Long-Term Follow-Up Trial of Oral Rifampin-Cotrimoxazole Combination versus Intravenous Cloxacillin in Treatment of Chronic Staphylococcal Osteomyelitis

  2009cited by this paper
• Systemic antimicrobial therapy in osteomyelitis.

  2009cited by this paper
• Treatment of pyogenic (non-tuberculous) spondylodiscitis with tailored high-dose levofloxacin plus rifampicin.

  2009cited by this paper
• Fosfomycin: use beyond urinary tract and gastrointestinal infections.

  2008cited by this paper
• Adjunctive use of rifampin for the treatment of Staphylococcus aureus infections: a systematic review of the literature.

  2008cited by this paper
• [Osteoarticular infections: therapeutic proposals of the Paediatric Infectious Diseases Group of the French Society of Paediatrics (GPIP)].

  2008cited by this paper
• Virulence characteristics of community-associated Staphylococcus aureus and in vitro activities of moxifloxacin alone and in combination against community-associated and healthcare-associated meticillin-resistant and -susceptible S. aureus.

  2008cited by this paper
• Levofloxacin plus rifampicin conservative treatment of 25 early staphylococcal infections of osteosynthetic devices for rigid internal fixation.

  2008cited by this paper
• Linezolid Alone or Combined with Rifampin against Methicillin-Resistant Staphylococcus aureus in Experimental Foreign-Body Infection

  2008cited by this paper
• Synergy between gemifloxacin and trimethoprim/sulfamethoxazole against community-associated methicillin-resistant Staphylococcus aureus.

  2008cited by this paper
• Antagonistic Effect of Rifampin on the Efficacy of High-Dose Levofloxacin in Staphylococcal Experimental Foreign-Body Infection

  2008cited by this paper
• Role of folate antagonists in the treatment of methicillin-resistant Staphylococcus aureus infection.

  2008cited by this paper
• Linezolid in the Treatment of Implant-related Chronic Osteomyelitis

  2007cited by this paper
• Suggestions for managing pyogenic (non-tuberculous) discitis in adults.

  2007cited by this paper
• [Pharmacokinetics and pharmacodynamics of antimicrobial therapy used in child osteoarticular infections].

  2007cited by this paper
• Efficacy and safety of linezolid for Gram-positive orthopedic infections: a prospective case series.

  2007cited by this paper
• Decreased Serum Linezolid Levels in a Critically Ill Patient Receiving Concomitant Linezolid and Rifampin

  2007cited by this paper
• Pharmacocinétique et pharmacodynamique sériques des antibiotiques utilisés dans les infections ostéoarticulaires de l'enfant

  2007cited by this paper
• Success of Short-Course Parenteral AntibioticTherapy for Acute Osteomyelitis of Childhood

  2007cited by this paper
• In Vivo Efficacy of Moxifloxacin Compared with Cloxacillin and Vancomycin in a Staphylococcus aureus Rabbit Arthritis Experimental Model

  2007cited by this paper
• Comparative Study of the Effects of Pyridoxine, Rifampin, and Renal Function on Hematological Adverse Events Induced by Linezolid

  2007cited by this paper
• Treatment of staphylococcal prosthetic joint infections with debridement, prosthesis retention and oral rifampicin and fusidic acid.

  2007cited by this paper
• Infections associated with long-term prosthetic devices.

  2007cited by this paper
• Pharmacokinetic considerations in the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis.

  2006cited by this paper
• Efficacy of High Doses of Levofloxacin in Experimental Foreign-Body Infection by Methicillin-Susceptible Staphylococcus aureus

  2006cited by this paper
• Community‐acquired methicillin‐resistant Staphylococcus aureus in bone and joint infections: development of rifampicin resistance

  2006cited by this paper
• Antimicrobial agents in orthopaedic surgery: Prophylaxis and treatment.

  2006cited by this paper
• Conservative treatment of staphylococcal prosthetic joint infections in elderly patients.

  2006cited by this paper
• Treatment of acute post-surgical infection of joint arthroplasty.

  2006cited by this paper
• Antibiotherapy of bone and joint infections

  2006cited by this paper
• Dumb and dumber--the potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureus.

  2006cited by this paper
• Multiple Combination Bactericidal Testing of Staphylococcal Biofilms from Implant-Associated Infections

  2006cited by this paper
• Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK.

  2006cited by this paper
• Antibiothérapie des infections ostéoarticulaires à pyogènes chez l'adulte : principes et modalités

  2006cited by this paper
• Penetration of moxifloxacin into bone in patients undergoing total knee arthroplasty.

  2006cited by this paper
• Diagnosis and treatment of infections associated with fracture-fixation devices.

  2006cited by this paper
• Successful oral pristinamycin therapy for osteoarticular infections due to methicillin-resistant Staphylococcus aureus (MRSA) and other Staphylococcus spp.

  2005cited by this paper
• The Effectiveness and Safety of Oral Linezolid for the Primary and Secondary Treatment of Osteomyelitis

  2005cited by this paper
• Antibiotic treatment of osteomyelitis: what have we learned from 30 years of clinical trials?

  2005cited by this paper
• Use of long-acting tetracyclines for methicillin-resistant Staphylococcus aureus infections: case series and review of the literature.

  2005cited by this paper
• Linezolid in the treatment of Gram-positive prosthetic joint infections.

  2005cited by this paper
• Comparative in-vitro activity of erythromycin, vancomycin and pristinamycin

  2005cited by this paper
• Adult osteomyelitis.

  2005cited by this paper
• Management of bone and joint infections due to Staphylococcus aureus

  2005cited by this paper
• Acute osteomyelitis and septic arthritis in children

  2005cited by this paper
• Trimethoprim‐Sulfamethoxazole as a Viable Treatment Option for Infections Caused by Methicillin‐Resistant Staphylococcus aureus

  2005cited by this paper
• Potential Clindamycin Resistance in Clindamycin-Susceptible, Erythromycin-Resistant Staphylococcus aureus: Report of a Clinical Failure

  2005cited by this paper
• Comparison of minimal inhibitory and mutant prevention drug concentrations of 4 fluoroquinolones against clinical isolates of methicillin-susceptible and -resistant Staphylococcus aureus.

  2004cited by this paper
• Linezolid-associated peripheral neuropathy.

  2004cited by this paper
• Osteomyelitis.

  2004cited by this paper
• Trimethoprim/Sulfamethoxazole for Treatment of Severe Staphylococcus aureus Infections

  2004cited by this paper
• Community-Acquired, Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Musculoskeletal Infections in Children

  2004cited by this paper
• A randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infection.

  2004cited by this paper
• Diffusion of levofloxacin into bone and synovial tissues.

  2004cited by this paper
• Place of newer quinolones and rifampicin in the treatment of Gram-positive bone and joint infections.

  2004cited by this paper
• Prosthetic-joint infections.

  2004cited by this paper
• Clinical Experience With Linezolid in Conjunction With Wound Coverage Techniques for Skin and Soft-Tissue Infections and Postoperative Osteomyelitis

  2004cited by this paper
• Antibiotic treatment of gram-positive bone and joint infections.

  2004cited by this paper
• Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro.

  2003cited by this paper
• Linezolid Penetration into Bone and Joint Tissues Infected with Methicillin-Resistant Staphylococci

  2003cited by this paper

• Polylactic acid/rifampicin/hydroxyapatite/GnPs 3D‐printable composites for targeted antibiotic delivery in bone infections

  2025cites this paper
• Nontuberculous Mycobacterial Lung Disease Management in Belgium: A Longitudinal Pharmacy Database Study

  2025cites this paper
• Population pharmacokinetics/pharmacodynamics of minocycline plus rifampicin in patients with complicated skin and skin structure infections caused by MRSA.

  2024cites this paper
• Development of Hybrid Implantable Local Release Systems Based on PLGA Nanoparticles with Applications in Bone Diseases

  2024cites this paper
• Multifunctional hydrogel based on silk fibroin/thermosensitive polymers supporting implant biomaterials in osteomyelitis

  2024cites this paper
• Vertebral osteomyelitis with Campylobacter jejuni – a case report and review of the literature of a very rare disease

  2024cites this paper
• Efficacy of single antibiotic therapy versus antibiotic combination in implant-free staphylococcal post-surgical spinal infections: a retrospective observational study

  2024cites this paper
• Which trial do we need? A randomized controlled trial comparing oral antibiotic monotherapy versus standard of care as antibiotic continuation treatment for the treatment of left-sided native valve bacterial endocarditis.

  2024cites this paper
• Metabolites augment oxidative stress to sensitize antibiotic-tolerant Staphylococcus aureus to fluoroquinolones

  2024cites this paper
• Real-Time Impedance-Based Monitoring of the Growth and Inhibition of Osteomyelitis Biofilm Pathogen Staphylococcus aureus Treated with Novel Bisphosphonate-Fluoroquinolone Antimicrobial Conjugates

  2023cites this paper
• Bovine Serum Albumin – Hydroxyapatite Nanoflowers as Potential Local Drug Delivery System of Ciprofloxacin

  2023cites this paper
• Antimicrobial Stewardship for Outpatients with Chronic Bone and Joint Infections in the Orthopaedic Clinic of an Academic Tertiary Hospital, South Africa

  2023influential citation
• Evaluation of the microbiota-sparing properties of the anti-staphylococcal antibiotic afabicin

  2023cites this paper
• Early switch from IV to oral antibiotic treatment in bone and joint infections.

  2023cites this paper
• Exploring Nanotechnology as a Strategy to Circumvent Antimicrobial Resistance in Bone and Joint Infections

  2023cites this paper
• Effect of the Biopolymer Carrier on Staphylococcus aureus Bacteriophage Lytic Activity

  2022cites this paper
• MIC Discrepancies between Parenteral and Oral Anti-Staphylococcal Beta-Lactams among MSSA

  2022cites this paper
• Gallium containing calcium phosphates: potential antibacterial agents or fictitious truth.

  2022cites this paper
• Characterization of Methicillin-Resistant Staphylococcus aureus Isolates from Periprosthetic Joint Infections

  2022cites this paper
• Mini Review Therapeutic Strategies Targeting for Biofilm and Bone Infections

  2022cites this paper
• PCL/Sodium-Alginate Based 3D-Printed Dual Drug Delivery System with Antibacterial Activity for Osteomyelitis Therapy

  2022cites this paper
• Tailored therapeutic release from polycaprolactone-silica hybrids for the treatment of osteomyelitis: antibiotic rifampicin and osteogenic silicates.

  2022cites this paper
• Repurposing the Antibacterial Activity of Etoposide─A Chemotherapeutic Drug in Combination with Eggshell-Derived Hydroxyapatite.

  2022cites this paper
• Influence of ceftriaxone on human bone cell viability and in vitro mineralization potential is concentration- and time-dependent

  2021cites this paper
• Italian consensus on the therapeutic management of uncomplicated acute hematogenous osteomyelitis in children

  2021cites this paper
• Safety and Tolerability of Fluoroquinolones for Periprosthetic Joint Infection.

  2021cites this paper
• Case report of infective spondylodiscitis due to nalidixic acid-resistant Salmonella paratyphi A

  2021cites this paper
• Bisphosphonates in dentistry: Historical perspectives, adverse effects, and novel applications.

  2021cites this paper
• Bacterial Antibiotic Resistance: The Most Critical Pathogens

  2021cites this paper
• Silver- and/or titanium-doped β-tricalcium phosphate bioceramic with antibacterial activity against Staphylococcus aureus

  2021cites this paper
• Campylobacter lari vertebral osteomyelitis.

  2021cites this paper
• Phage Activity against Planktonic and Biofilm Staphylococcus aureus Periprosthetic Joint Infection Isolates

  2021cites this paper
• Management of chronic osteomyelitis of the femur and tibia: a scoping review

  2021cites this paper
• Bone and joint infections caused by Clostridium perfringens: a case series

  2021cites this paper
• Oral Flucloxacillin for Treating Osteomyelitis: A Narrative Review of Clinical Practice

  2020cites this paper
• Advance Publication by J-STAGE

  2020cites this paper
• Nanotechnology in Skin, Soft Tissue, and Bone Infections

  2020cites this paper
• Synthesis and characterization of antibacterial drug loaded β-tricalcium phosphate powders for bone engineering applications

  2020cites this paper
• Diabetic Foot Osteomyelitis: Control and Therapy Through Nanotechnology

  2020cites this paper
• Acute infectious osteomyelitis in children: new treatment strategies for an old enemy

  2020cites this paper
• Staphylococcus aureus Prostatic Abscess in the Setting of Prolonged S. aureus Bacteremia

  2020cites this paper
• Physiologically Based Population Pharmacokinetic Modeling Approach for Ciprofloxacin in Bone of Patients Undergoing Orthopedic Surgery.

  2020cites this paper
• A case of deep vein thrombosis associated with methicillin sensitive Staphylococcal aureus genu septic arthritis

  2020cites this paper
• Bisphosphonates for delivering drugs to bone

  2020cites this paper
• Poly(Aspartic Acid) Functionalized Poly(ϵ-Caprolactone) Microspheres with Enhanced Hydroxyapatite Affinity as Bone Targeting Antibiotic Carriers

  2020cites this paper
• Clindamycin combination treatment for the treatment of bone and joint infections caused by clindamycin-susceptible, erythromycin-resistant Staphylococcus spp.

  2020cites this paper
• Novel approaches for the treatment of methicillin-resistant Staphylococcus aureus: using nanoparticles to overcome multidrug resistance.

  2020cites this paper
• Adjunctive Use of Phage Sb-1 in Antibiotics Enhances Inhibitory Biofilm Growth Activity versus Rifampin-Resistant Staphylococcus aureus Strains

  2020cites this paper
• Staphylococcus aureus a Gram-positive Coccid Bacterium CausingMicrobial Infections, and Toxins Symptoms Including Food Poisoning

  2020cites this paper
• Causative Pathogens and Antibiotic Resistance in Infectious Arthritis

  2020cites this paper
• Cefuroxime conjugated chitosan hydrogel for treatment of wound infections.

  2019cites this paper
• Hip and Knee Section, Treatment, Antimicrobials: Proceedings of International Consensus on Orthopedic Infections.

  2019cites this paper
• Arthrite septique à pyogène de l’adulte

  2019cites this paper
• Artritis séptica por piógenos en el adulto

  2019cites this paper
• Osteoarticular infections: a specific program for older patients?

  2019cites this paper
• In vivo biochemical evaluations of some β-lactam group antibiotics on glutathione reductase and glutathione S- transferase enzyme activities.

  2019cites this paper
• Systemic antibiotic treatment of chronic osteomyelitis in adults.

  2019cites this paper
• Silver nanoparticles present high intracellular and extracellular killing against Staphylococcus aureus.

  2019cites this paper
• A review on recent development on fluoroquinolones

  2019cites this paper
• Selection of an appropriate empiric antibiotic regimen in hematogenous vertebral osteomyelitis

  2019cites this paper
• A Biofilm-Based Approach to the Diagnosis and Management of Postoperative Spine Infection

  2019cites this paper
• Clindamycin inhibits nociceptive response by reducing tumor necrosis factor-α and CXCL-1 production and activating opioidergic mechanisms

  2019cites this paper
• Targeting Biofilms in Translational Research, Device Development, and Industrial Sectors

  2019cites this paper
• Synthesis of polymeric nanocapsules for levofloxacin delivery against Staphylococcus aureus

  2018cites this paper
• SA-7 Os Humerus Amputation in Cat with Osteomyelitis

  2018cites this paper
• Preventing S. aureus biofilm formation on titanium surfaces by the release of antimicrobial β-peptides from polyelectrolyte multilayers

  2018cites this paper
• Osseointegrated Percutaneous Prosthetic System for the Treatment of Patients With Transfemoral Amputation: A Prospective Five-year Follow-up of Patient-reported Outcomes and Complications

  2018cites this paper
• 100 – Clinical Syndromes of Device-Associated Infections

  2018cites this paper
• In vitro performances of novel co-spray-dried azithromycin/rifampicin microparticles for Rhodococcus equi disease treatment

  2018cites this paper
• Therapeutic outcome of spinal implant infections caused by Staphylococcus aureus

  2018cites this paper
• Old antimicrobials and Gram-positive cocci through the example of infective endocarditis and bone and joint infections.

  2017cites this paper
• Design, Synthesis, and Antimicrobial Evaluation of a Novel Bone-Targeting Bisphosphonate-Ciprofloxacin Conjugate for the Treatment of Osteomyelitis Biofilms.

  2017influential citation
• Diabetic foot infection: Antibiotic therapy and good practice recommendations

  2017cites this paper
• Development of Subsequent Bacteremia or Fungemia after

  2016cites this paper
• In vitro synergistic effects of various combinations of vancomycin and non-beta-lactams against Staphylococcus aureus with reduced susceptibility to vancomycin.

  2016cites this paper
• Novel Alginate–Chitosan Composite Microspheres for Implant Delivery of Vancomycin and In Vivo Evaluation

  2016cites this paper
• Evaluation of antibiotic resistance to orally administrable antibiotics in staphylococcal bone and joint infections in one of the largest university hospitals in Germany: is there a role for fusidic acid?

  2016cites this paper
• Reply to Bernard et al.

  2016cites this paper
• Multidrug-Resistant Gram-Positive Bacterial Infections

  2015cites this paper
• An update on surgical and antimicrobial therapy for acute periprosthetic joint infection: new challenges for the present and the future

  2015influential citation
• Immunomodulatory Peptide IDR-1018 Decreases Implant Infection and Preserves Osseointegration

  2015cites this paper
• Clinical Importance and Epidemiology of Quinolone Resistance

  2014cites this paper
• Oral Antimicrobial Therapy: Efficacy and Safety for Methicillin-Resistant Staphylococcus aureus Infections and Its Impact on the Length of Hospital Stay

  2014cites this paper
• Clinical Importance and Epidemiology of Quinolone Resistance this access benefits you. Your story matters

  2014cites this paper
• Increased Release Time of Antibiotics from Bone Allografts through a Novel Biodegradable Coating

  2014cites this paper